The generic name of Medobar is Dobasic Hydrazide Tablets and this medication is usually useful in the early stages of Parkinson’s. Dobasic Hydrazide Tablet is an anti-Parkinson’s disease medication used in Parkinson’s disease, symptomatic Parkinson’s syndrome and other disorders. Dobasic hydrazide tablets are made by combining levodopa with benserazide, an intermediate of dopamine, which is produced by the action of the enzyme aromatic L-amino acid decarboxylase. The dopamine content in the basal ganglia of the brain is deficient in Parkinson’s disease patients, therefore, patients with early Parkinson’s disease can take dobasic hydrazide tablets to improve their clinical symptoms. In addition, dopamine agonists such as ropinirole and pramipexole hydrochloride are also commonly used in the early stage of Parkinson’s disease. Parkinson’s patients are recommended to seek timely medical treatment, standardized treatment under the guidance of the doctor, and take medication in strict compliance with the doctor’s instructions.